Download FREE Report Sample
Download Free sampleGlutamate Receptor Ionotropic NMDA 2B Market contains market size and forecasts of Glutamate Receptor Ionotropic NMDA 2B in global, including the following market information:
Global Glutamate Receptor Ionotropic NMDA 2B Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Glutamate Receptor Ionotropic NMDA 2B Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Glutamate Receptor Ionotropic NMDA 2B companies in 2021 (%)
The global Glutamate Receptor Ionotropic NMDA 2B market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
JNJ-0808 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glutamate Receptor Ionotropic NMDA 2B include BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG and UCB S.A., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glutamate Receptor Ionotropic NMDA 2B manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glutamate Receptor Ionotropic NMDA 2B Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Glutamate Receptor Ionotropic NMDA 2B Market Segment Percentages, by Type, 2021 (%)
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others
Global Glutamate Receptor Ionotropic NMDA 2B Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Glutamate Receptor Ionotropic NMDA 2B Market Segment Percentages, by Application, 2021 (%)
Acute Ischemic Stroke
Autism
Brain Ischemia
Burns
Others
Global Glutamate Receptor Ionotropic NMDA 2B Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Glutamate Receptor Ionotropic NMDA 2B Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glutamate Receptor Ionotropic NMDA 2B revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Glutamate Receptor Ionotropic NMDA 2B revenues share in global market, 2021 (%)
Key companies Glutamate Receptor Ionotropic NMDA 2B sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Glutamate Receptor Ionotropic NMDA 2B sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
